US 11534430
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
granted A61KA61K31/337A61K31/436
Quick answer
US patent 11534430 (Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs) held by Lutonix, Inc. expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lutonix, Inc.
- Grant date
- Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/337, A61K31/436, A61K9/0019, A61K9/0073